tirzepatide by eli lilly (LLY) Gets Nod to Launch Weight-Loss Drug Mounjaro in Hong Kong Lilly releases Zepbound® (tirzepatide) single-dose
Description
Low-appetite days are not the time to dig behind jars of mustard like you are on a tiny kitchen treasure hunt
How much should we pay to add a year of life
Newer incretin-based medications like semaglutide and tirzepatide have changed obesity treatment by producing substantial weight loss, but their effects on neuropsychiatric health remain uncertain in routine clinical practice
It is not listed in the British National Formulary (BNF), and no NICE technology appraisal exists for it
The patient may remain at a dose that provides an appropriate balance of results, safety, and manageable side effects
